Kolexia
Israel-Biet Dominique
Pneumologie
Hôpital Européen Georges Pompidou
Paris, France
179 Activités
129 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Fibrose Fibrose pulmonaire Fibrose pulmonaire idiopathique Maladies pulmonaires Pneumopathies interstitielles Sarcoïdose Hypertension pulmonaire Prédisposition génétique à une maladie Hypertension artérielle

Industries

RE-IMAGINE Health Agency
16 collaboration(s)
Dernière en 2021
Boehringer Ingelheim
11 collaboration(s)
Dernière en 2023
Roche
5 collaboration(s)
Dernière en 2021
FREQUENCE MEDICALE
1 collaboration(s)
Dernière en 2023

Dernières activités

TETON-2: A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-2)
Essai Clinique (United Therapeutics)   14 mars 2024
High-Risk Sarcoidosis: A Focus on Pulmonary, Cardiac, Hepatic and Renal Advanced Diseases, as Well as on Calcium Metabolism Abnormalities.
Diagnostics (Basel, Switzerland)   11 février 2024
AIR: Circulating Tumor Cells and Early Diagnosis of Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease
Essai Clinique (CHU Nice)   05 février 2024
An adjudication algorithm for respiratory-related hospitalisation in idiopathic pulmonary fibrosis.
ERJ open research   29 janvier 2024
Impact of Air Pollution and MUC5B Genotype on Survival in Idiopathic Pulmonary Fibrosis.
Annals of the American Thoracic Society   14 décembre 2023
U-net convolutional neural network applied to progressive fibrotic interstitial lung disease: Is progression at CT scan associated with a clinical outcome?
Respiratory medicine and research   02 novembre 2023
Prognostic impact of venous thromboembolism on the course of sarcoidosis: A multicenter retrospective case-control study.
Respiratory medicine and research   23 septembre 2023
Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial.
The European respiratory journal   08 juin 2023
Autoantibodies are associated with disease progression in idiopathic pulmonary fibrosis.
The European respiratory journal   18 mai 2023
Impact de la pollution atmosphérique sur la survie de la fibrose pulmonaire idiopathique selon le polymorphisme MUC5B
27e Congrès de Pneumologie de Langue Française   01 janvier 2023